α-Glucosidase-IN-22 |
| Catalog No.GC70181 |
α-Glucosidase-IN-22 (composé 7i) est un benzimidazole, un inhibiteur efficace de l'α-glucosidase avec une IC50 de 0,64 μM. α-Glucosidase-IN-22 est une molécule active contre le diabète sucré et possède un potentiel pour la recherche sur le diabète de type 2 (T2DM).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2870693-28-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for α-Glucosidase-IN-22
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for α-Glucosidase-IN-22
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *